Managed Access Program

Managed Access Program

AtrimusRx, your trusted partner in the Nordic region.

Managed access program

Patients with serious or life-threatening diseases may seek medical products and treatments that are not yet approved or available in their country. AtrimusRx Managed access program addresses this need by making certain investigational or unapproved pharmaceuticals available to the patients and healthcare physicians.

In such cases, the treating physician can request an investigational product prior to regulatory approval or a pharmaceutical that has recently been approved and commercially available outside of local region to be imported and supplied to the patient or a clinic. This process is monitored by the local health authorities and the treatment is always subsidised.

Here at AtrimusRx we have the extensive knowledge of the regulatory requirements in the market and have an excellent distribution network that covers the entire Nordic within one business day.


Ordering a MAP product:

To initiate a MAP program:

+46 8 551 096 19